Life Sciences & Healthcare
The sheer scale of change and disruption happening in healthcare and the life science industry may be unprecedented. We all relied on life science and healthcare to lead the way out of the pandemic – and they rose to the occasion spectacularly, accelerating vaccine trials and shedding their tech-averse image by embracing technology-driven innovation.
This change in attitudes has led to an eruption of innovation in the sector, which poses its own challenges. New processes around clinical trials demand new ways of observation and measurement. This must be underpinned by the right hardware and software – and all of this must comply with some of the strictest regulations to be found anywhere.
Eruption of innovation
The sudden shift to remote, decentralized, and hybrid clinical trials in 2020 was transformative. The industry worked closely with regulators across the globe to rapidly adapt regulations and ensure progress.
One result of this is that patients have quickly become more accepting of remote healthcare solutions, which has driven growth in supporting technologies. Remote patient monitoring (RPM) solutions, robotics and automation, telehealth, electronic clinical-outcome assessments, and Internet-of-Things (IoT) wearables and sensors are now firmly established parts of the healthcare process and are here to stay.
Organizations are responding by investing in the future, from new therapeutic devices to IoT sensors – and the IT services, infrastructures, and apps that power them. This means a steep learning curve for organizations that haven’t had to worry about things like application development before, let alone the development and validation of critical software embedded in devices and sensors.
Our long-term investments in the market’s strongest tech talent means Akkodis is ideally placed to support life science and healthcare companies across the entire value chain as they evaluate and implement these new and nascent technologies.
Regulatory changes and challenges
This new era of healthcare optimization has been welcomed by patients and providers alike, but also poses new challenges – especially regulatory ones.
Life science and healthcare are among the most heavily regulated industries worldwide. This cannot and will not change, because patient and customer welfare will always be the top priority. But as healthcare technology advancements continue to give patients more autonomy in healthcare, regulators must adapt.
This means more shared access to data on trials and real-world evidence – a trend that began with the growth of patient-focused drug development but was vastly accelerated by the pandemic. In turn, this requires new, more interoperable IT systems (often cloud-based) at regulators, in pharmaceutical manufacturing, and among healthcare providers, while maintaining compliance with regulations like HIPAA and GDPR.
At Akkodis, our people are our strongest asset – our tech talent combines unrivaled knowledge of the industry’s regulatory landscape with full-stack technology expertise. This enables us to support healthcare and life science organizations to explore the benefits of tech while remaining compliant.
Digital transformation is a must
The part of this industry-wide wave of change that everyone wants to talk about is the use of technologies like IoT in patient care and supply chain management. It goes alongside ever-increasing automation and robotization that promises to revolutionize healthcare provision (especially in under-served communities). But to make this all work, healthcare and life science organizations need to have the right infrastructure, IT services, and digital tools in place.
Akkodis’ combination of deep industry knowledge and the market’s strongest tech talent means we’re able to help organizations across the whole sector as they migrate their IT to the cloud, implement new enterprise resource planning (ERP) solutions, and develop apps and multi-experience user interfaces.
Years of domain experience
Innovation in healthcare
Advancements in medical devices
Modernization in cosmetics
Innovation in healthcareThe regulatory landscape in healthcare can be tough to navigate as providers seek to implement new technologies while remaining compliant. That’s why Akkodis is on hand to offer healthcare providers and suppliers regulatory affairs management, pharmacovigilance services, and patient-support program development. We also offer the full stack of IT services for the healthcare industry.
Advancements in medical devicesAs well as our regulatory compliance services, medical device manufacturers will benefit greatly from our range of targeted services. These include product/device development and engineering, robotics, and automation, IoT sensors and warehouse and supply chain management, predictive maintenance, and more.
Modernization in cosmeticsCosmetics industry players recognize the need to digitally transform their operations and supply chains, and Akkodis has a suite of solutions and services to achieve this. Whether it’s an implementation of ERP in corporate, or IoT and predictive maintenance in manufacturing and warehouse facilities, we’ve got it covered – and our regulatory expertise will ensure you remain in compliance at every step.
We understand that our people are our greatest strength. That’s why we seek out the market’s strongest tech talent and regulatory expertise, so we’re able to guide all kinds of healthcare and life science companies through the transformations to come.